The largest database of trusted experimental protocols

10 protocols using anti cd56

1

Expanding and Transducing Natural Killer Cells from Umbilical Cord Blood

Check if the same lab product or an alternative is used in the 5 most similar protocols
UCB units were provided from StemCyte under IRB-approved protocols. All donors provided written informed consent, which followed the ethical guidelines of the Declaration of Helsinki. NK cells were isolated by using the RosetteSepTM human NK cell enrichment cocktail (Cat# 15065, StemCell Technologies) and Ficoll-Paque (Cat# 17144003, Cytiva). The purity of primary NK cells was confirmed with flow cytometry using anti-CD56 (Cat# IM2474U, Beckman Coulter; 1:20 dilution) and anti-CD3 (Cat# 130-113-134, Miltenyi Biotec; 1:50 dilution) antibodies. Frozen UCB NK cells were thawed and expanded with irradiated K562 feeder cells expressing membrane-bound IL-21 and 4-1BBL (APC K562) in the presence of recombinant human IL-2 (50 IU/ml; NIH) in Stem Cell Growth Medium (SCGM) (Cat# 20802-0500, CellGenix). Expanded NK cells were transduced with retrovirus on day 5 in RetroNectin (Cat# T202, Takara Bio)-coated plates, according to the manufacturer’s protocol. On day 8, NK cells were co-cultured with irradiated APC K562 cells for an additional 7 days prior to being harvested for in vitro analysis or frozen (liquid nitrogen) for in vitro and in vivo studies. All NK cells used in our study did not undergo further purification, except where specifically indicated. Information on flow antibodies was presented in Supplementary Table 1.
+ Open protocol
+ Expand
2

Phenotyping of Mononuclear Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Phenotyping of mononuclear cells was performed in 1% BSA and 3% human serum-PBS according to standard methods using a panel of antibodies directed against monocytes, T- and B-lymphocytes, natural killer cells and red cells. The following conjugated antibodies were used: anti-CD19 (Beckman Coulter Cat# IM1284U, RRID:AB_131011), anti-CD56 (Beckman Coulter Cat# IM2073U, RRID:AB_131195), anti-CD3 (Beckman Coulter Cat# IM1282U, RRID:AB_10640418), anti-CD14 (Beckman Coulter Cat# IM0645U, RRID:AB_130992), anti-CD16 (Beckman Coulter Cat# IM0814U, RRID:AB_10640417) were from Beckman Coulter (FL). FACS analysis was performed on a LSRII cytometer (BD Biosciences, CA). Mø phenotype was confirmed by flow cytometry targeting CD68 (R and D Systems Cat# IC20401P, RRID:AB_2074835) and CD80 (R and D Systems Cat# FAB140F, RRID:AB_357027), CD163 (R and D Systems Cat# FAB1607P, RRID:AB_2074536) and CD206 (R and D Systems Cat# FAB25342P, RRID:AB_10889015) antibodies all from R&D Systems (IN). Data were analyzed with Flowing Software (University of Turku, Finland) or FACSDiVa software (BD Biosciences) and represented, when required, with the logical display.
+ Open protocol
+ Expand
3

Multiparametric Flow Cytometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Surface phenotypes were determined using an Epics XL MCL (Beckman Coulter, Brea, CA, USA). The following monoclonal antibodies (mAbs) were purchased from Beckman Coulter: anti‐CD3, anti‐CD4, anti‐CD8, anti‐Vγ9TCR, anti‐CD14, anti‐CD25, anti‐CD45, anti‐CD54, anti‐CD56, anti‐HLA‐DR, anti‐CD40, anti‐CD80, anti‐CD86, anti‐CD11c, anti‐CD36, mouse immunoglobulin (Ig)G1, mouse IgG2 and mouse IgG2b mAbs. Anti‐HLA‐class 1 and anti‐CCR7 mAbs were purchased from Beckton Dickinson (San Jose, CA, USA) and R&D Systems (Minneapolis, MN, USA), respectively. Anti‐TCR Vα24TCR and anti‐TCR Vβ11 mAbs were purchased from Beckman Coulter (Villepinte, France). Anti‐human CD273 (PD‐L2) and CD274 (PD‐L1) mAbs were purchased form eBioscience (San Diego, CA, USA). Anti‐human CD152 (CTLA‐4) and CD279 (PD‐1) mAbs were purchased from BioLegend (San Diego, CA, USA). Anti‐FoxP3 mAb for intracellular staining was purchased from BD Biosciences (Tokyo, Japan). All mAbs were conjugated with fluorescein isothiocyanate (FITC), phycoerythrin (PE), antigen‐presenting cells (APC), extracellular domain (ECD), proprotein convertase (PC)5 or PC7. Z was purchased from Novartis Pharmaceuticals (Basel, Switzerland) and G from Funakoshi Co. Ltd (Tokyo, Japan).
+ Open protocol
+ Expand
4

Lymphocyte Subset Profiling by Flow Cytometry

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell surface markers of peripheral blood mononuclear cells were measured by flow cytometry (NAVIOS; Beckman Coulter) with immunofluorescent staining using anti-CD3, anti-CD4, anti CD8, anti-CD19, anti-CD16, and anti-CD56 antibodies (Beckman Coulter). T-cell receptor (TCR) v-β expression was determined as directed by the manufacturer (Beta Mark TCR v-β Repertoire Kit; Beckman Coulter). Reference range for lymphocyte subsets in adults were taken from Apoil et al. (15 (link))
+ Open protocol
+ Expand
5

Multiparametric Flow Cytometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were incubated with fluorochrome-conjugated mAbs and analyzed on either an FC 500 (Beckman Coulter; Miami, FL) or an LSRFortessa (Becton Dickinson) flow cytometer with quadrants set to score > 99% of fluorochrome-conjugated mouse immunoglobulin (Ig) isotype controls (BD Pharmingen and DakoCytomation; Carpinteria, CA) as negative. FITC-, PE-, ECD-, APC-, PE-Cy5-, PE-Cy7-, PerCP-Cy5.5-, and AF700-conjugated mouse anti-human mAbs included anti-CD16 (clone 3G8), anti-NKG2D (clone 1D11), anti-CD117, anti-CD127, anti-CD14, anti-HLA-DR, and anti-CD86 (BD Pharmingen); anti-CD3, anti-CD56, anti-NKp46, and anti-CD83 (Beckman Coulter); and anti-NKB1 (clone DX9) (BioLegend; San Diego, CA). MAbs for sorting were specified above. DAPI (Invitrogen) was used to exclude dead cells. Flow cytometric data were analyzed with FlowJo 9.5 software (TreeStar; Ashland, OR).
+ Open protocol
+ Expand
6

Isolation and Characterization of Primary NK Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood leukopacks were obtained from City of Hope National Medical Center Blood Bank under the institutional review board approved protocols. NK cells were isolated by using the RosetteSep human NK cell enrichment cocktail (StemCell Technologies) and Ficoll-Paque (GE Healthcare). The purity of primary NK cells was confirmed with flow cytometry using anti-CD56 (Beckman Coulter, Cat# B46024) and anti-CD3 (Miltenyi Biotec, Cat# 130-113-134) antibodies. CD3CD56bright, CD3CD56dim NK cells and total NK cells co-cultured with tumor cells were sorted using an Aria Fusion sorter (BD Biosciences).
+ Open protocol
+ Expand
7

Comprehensive Multiparametric Flow Cytometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMCs were incubated with fluorochrome-conjugated mAbs and analyzed on either an FC 500 (Beckman Coulter) or an LSRFortessa (Becton Dickinson) flow cytometer. FITC-, PE-, PE-Texas Red-, ECD-, APC-, PE-Cy5–, PE-Cy7–, PerCP-Cy5.5–, Pacific Blue-, and AF700-conjugated mouse anti-human mAbs included anti-CD3, anti-CD4, anti-CD8, anti-CD11c, anti-CD14, anti-CD16 (clone 3G8), anti-CD19, anti-CD25, ant-CD28, anti-CD45RA, anti-CD45RO, anti-CD80, anti-CD86, anti-CD123, anti-CTLA-4, anti–HLA-DR, anti-IL2, anti-Ki-67 (BD Pharmingen), anti-CD56, anti-CD83 (Beckman Coulter), anti-CD127, anti- IFNγ, anti-LAG-3, anti-PD-1, anti- TNFα (eBioscience), anti-CCR7, anti-TIM-3 (R&D Systems), and anti-CD57 (BioLegend). Nonreactive isotype-matched antibodies (Becton Dickinson, eBioscience, R&D Systems) were used as controls. LIVE/DEAD Fixable Aqua Dead Cell Stain Kit (Life Technologies) facilitated exclusion of dead cells. Gates were set for collection and analysis of at least 20,000 live events. Data were analyzed with FlowJo 9.5 software (TreeStar).
+ Open protocol
+ Expand
8

NK Cell-Mediated Cytotoxicity Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
mACE2-CAR_sIL15 NK and control NK cells were co-cultured with A549 or A549-spike cells at an E/T ratio of 4:1 for 4 h in a 96-well U-bottom plate. Anti-CD107a monoclonal antibody (mAb) (Cat# 563869, BD; 1:200 dilution) and GolgiPlug (1:1000 dilution) (Cat# 555029, BD) were added to cultures at the start of incubation. Cells were stained with anti-CD56 (Cat# IM2474U, Beckman Coulter; 1:20 dilution), anti-LNGFR (Cat# 557196, BD; 1:20 dilution) or anti-EGFR (Cat# 352904, BioLegend; 1:50 dilution) mAbs and then stained intracellularly with IFN-γ (Cat# 563563, BD; 1:20 dilution) and TNF-α (Cat# 557647, BD; 1:20 dilution) mAbs. The stained cells were analyzed by flow cytometry, and the data were analyzed with FlowJo software.
+ Open protocol
+ Expand
9

Phenotypic Analysis of NK Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Monoclonal antibodies (mABs) used for phenotypic analysis included Fluorescein isothiocyanate (FITC)-, Phycoerythrin (PE)-, Phycoerythrin Cyanine 5.5 and allophycocyanin (APC)-labeled anti-CD45, anti-CD3, anti-CD56, NKp30, NKp44 (Beckman Coulter, Brea, CA, USA), anti-CD16, NKp46, NKG2A (R&D System), anti-CD94, anti-CD69, anti-CD18, anti-CD49, anti-CD62L, anti-CD38 and CXCR4 (BD Pharmingen, San Jose, CA, USA). Phenotype evaluation was performed by direct immunofluorescence according to previously reported methods [29 (link)]. NK cells recovered from immunodeficient NOD/SCID gamma (NSG) mice were stained with anti-mouse CD45-APC-Cy7, anti-human CD45-PE-Cy7, CD3-PerCP-Cy5.5, CD56-FITC (Biolegend, San Diego, CA, USA) and CD94-APC (BD).
+ Open protocol
+ Expand
10

Comprehensive Lymphocyte Subset Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The leukapheresis products were suspended in RPMI 1640 medium (Life Technologies, Carlsbad, CA, USA) supplemented with 10% fetal calf serum and were analyzed using flow cytometry. Eight-colour analyses were performed for the identification of the lymphocyte subsets with the following monoclonal antibodies: CD2, CD3, CD4, CD5, CD7, CD16, CD25, CD56, CD45, CD45RA, CD45RO, CD9, CD127, CCR7, and HLA-DR antigens. All antibodies were purchased from BD Biosciences (San José, CA, USA) except for anti-CD8, anti-CD56, and anti-CD127 which were purchased from Beckman Coulter (Brea, CA, USA); anti-CCR7 was purchased from R&D systems (MN, USA) and anti HLA-DR from Biolegend (San Diego, CA, USA). The Blood Dendritic Cell Enumeration Kit (Miltenyi Biotech GmbH, Bergish Gladbach, Germany) was used according to the supplier's protocol to determine plasmacytoid dendritic cells, type 1 and type 2 myeloid dendritic cells. Flow cytometry analysis was performed on the LSR II instrument (BD Biosciences). Data analysis was performed using the Flow-Jo software (Tree Star, Ashland, OR, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!